fda glp-1 compounding enforcement news october 2025 Ozempic's patent problem: how Novo Nordisk lost control of a blockbuster drug. 💉 Demand for weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Last month, the FDA issued

Herstellung in Deutschland: nach klar definierten Qualittsstandards

Recent data has also confirmed that when patients stop treatment they regain lost weight. Using AI to identify Ozempic-like plant extracts Murcia and her colleagues used high-performance AI techniques to identify non-peptide natural compounds that can activate the GLP-1 receptor

Batch 5666 tested at 98.82% purity by independent HPLC at Testides Analytical

They mimic a natural hormone that controls blood sugar and hunger

The two drugs licensed for obesity are manufactured by Novo Nordisk

But the experts say its a good idea for people who struggle to get enough via diet alone to supplement with protein powders or premade shakes